Development of the next generation of Alzheimer’s disease drugs is currently presented in Boston:

The primary objective of a clinical trial should be clearly defined with regard to the target of estimation (estimand) for the efficacy of an investigational drug. The fully specified treatment effect of interest should then determine the data collection, data… Continue Reading →

Abstracts are available. Astracts CTAD 2017